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Bidirectional and context-
dependent changes in theta and 
gamma oscillatory brain activity 
in noradrenergic cell-specific 
Hypocretin/Orexin receptor 1-KO 
mice
Sha Li1, Paul Franken2 & Anne Vassalli  1
Noradrenaline (NA) and hypocretins/orexins (HCRT), and their receptors, dynamically modulate the 
circuits that configure behavioral states, and their associated oscillatory activities. Salient stimuli 
activate spiking of locus coeruleus noradrenergic (NALC) cells, inducing NA release and brain-wide 
noradrenergic signalling, thus resetting network activity, and mediating an orienting response. 
Hypothalamic HCRT neurons provide one of the densest input to NALC cells. To functionally address 
the HCRT-to-NA connection, we selectively disrupted the Hcrtr1 gene in NA neurons, and analyzed 
resulting (Hcrtr1Dbh-CKO) mice’, and their control littermates’ electrocortical response in several contexts 
of enhanced arousal. Under enforced wakefulness (EW), or after cage change (CC), Hcrtr1Dbh-CKO  
mice exhibited a weakened ability to lower infra-θ frequencies (1–7 Hz), and mount a robust, narrow-
bandwidth, high-frequency θ rhythm (~8.5 Hz). A fast-γ (55–80 Hz) response, whose dynamics 
closely parallelled θ, also diminished, while β/slow-γ activity (15–45 Hz) increased. Furthermore, 
EW-associated locomotion was lower. Surprisingly, nestbuilding-associated wakefulness, inversely, 
featured enhanced θ and fast-γ activities. Thus HCRT-to-NA signalling may fine-tune arousal, up in 
alarming conditions, and down during self-motivated, goal-driven behaviors. Lastly, slow-wave-sleep 
following EW and CC, but not nestbuilding, was severely deficient in slow-δ waves (0.75–2.25 Hz), 
suggesting that HCRT-to-NA signalling regulates the slow-δ rebound characterizing sleep after stress-
associated arousal.
Electrical brain waves (or oscillations) can be used to define behavioral domains called vigilance (or 
behavioral) states. At any time, an animal appears to be in one of three ‘global brain states’, wakefulness, 
non-rapid-eye-movement (NREM) sleep (or slow-wave-sleep in rodents), and REM (or paradoxical) sleep, as 
assessed by the oscillatory profile measured in the electroencephalogram (EEG, or electrocorticogram (ECoG) in 
rodents). EEG signals provide information at a high-temporal resolution (10–100 ms) about an animal’s arousal 
state, behavior, and prior sleep/wake history. Behavioral states were also found to delineate distinct physiological 
and molecular brain milieus, e.g.1,2. Furthermore, increasing evidence suggests that oscillatory patterns are active 
functional determinants of brain circuits processing, and their behavioral outcomes, e.g.3–6.
State-specific oscillations emerge from dynamic neuronal activity in interconnected cortical and subcortical 
microcircuits responding to external stimuli and a multitude of internal indices of the animal’s circadian, home-
ostatic, and motivational state. Many of these signals are implemented by a set of key neuromodulators (acetyl-
choline, histamine, noradrenaline [NA], serotonin, dopamine, and hypocretin-1 and 2/orexin-A and B [HCRT]), 
produced in a set of subcortical arousal ‘hubs’, that are active when the animal is awake, but mostly silent in 
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Figure 1. Conditional inactivation of Hcrtr1 in noradrenaline (NA) neurons: TH+ cells in the locus coeruleus 
of Hcrtr1Dbh-CKO (CKO) mice express GFP in place of HCRTR1. (a) Schematic representation of homologous 
recombination between the Hcrtr1 genomic locus and the targeting vector (TSS, transcription start site; filled 
rectangles depict protein-coding sequences, and unfilled rectangles represent untranslated regions). Two loxP 
sites (red triangles) were inserted to flank the first coding exon (exon 3) and exon 4, which together encode the 
N-terminal first 126 aa of HCRTR1. The neomycin resistance gene used for selection in embryonic stem cells 
(neo; flanked by two FRT sites shown as orange triangles) was deleted using the FLP recombinase, creating 
the Hcrtr1flox allele. In TgDbh-Cre-expressing cells, CRE excises the inter-loxP fragment (1.1 kb), creating the 
Hcrtr1+/KO-Gfp allele. In the latter, the translation start site (ATG) of Hcrtr1 is replaced by the ATG of the Gfp 
cassette. Thus Gfp expression (green rectangle) becomes regulated by the Hcrtr1 promoter. Gfp reading frame 
is followed by a polyadenylation site (pA) to terminate transcription and prevent downstream expression. (b–f) 
Representative confocal images of the locus coeruleus (LC) of mice of the indicated genotypes. Noradrenergic 
(NA) neurons are stained with a tyrosine hydroxylase antibody (TH+). Costaining with a CRE (b), GFP 
(c,d), or HCRTR1 (e,f) antibody is depicted. (b) shows that CRE is efficiently and specifically expressed in 
LC TH+ cells of a CKO mouse. (c) CKO mice express GFP in place of HCRTR1 in LC TH+ cells, while, in 
absence of CRE, (d) a CTR mouse lacks GFP immunoreactivity. (f) HCRTR1 immunoreactivity can be seen 
in LC TH+ cells of a CTR mouse, but not appreciably in LC TH+ cells of a CKO mouse (e). The CKO mouse 
exhibits however HCRTR1-immunoreactive, TH-negative cells outside the LC nucleus, consistently with NA 
cell-selective Hcrtr1 gene disruption. The HCRTR1 antibody was raised against a peptide encoded by regions 
downstream of the CRE-mediated deletion. (g–i) Quantification of the percentage of TH+ neurons that are also 
immunoreactive for CRE (g), GFP (h), or HCRTR1 (i). Coronal sections collected at four levels throughout the 
LC were quantitatively assessed. Data are mean ± SEM values for (g,h) CKO (n = 3 for each), or (i) CKO (n = 3) 
and CTR (n = 4) mice. Boxed areas (and images to the right) represent fields delineated for cell counts (see 
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NREM sleep. Although all these neuromodulator-producing neurons regulate waking states and attention, they 
widely differ in their neuroanatomical and electrophysiological properties, the contexts that activate them, and 
the downstream effectors they act upon, and their behavioral translation7,8. The complex interplays between these 
neuromodulators are poorly understood.
HCRT and NA are produced by neurons residing in, respectively, the lateral hypothalamus and a set of pon-
tomedullary NA nuclei9, of which the locus coeruleus (LC) is the best characterized. Each cell group receives 
multiple inputs and broadcasts to many nuclei, including to each other10. LC provides approximately half of all 
brain NA11, and all the neocortical and hippocampal NA. LC cells fire tonically at a frequency that is behavioral 
state-dependent, and in waking tends to increase with arousal level12. In response to salient stimuli, LC neurons 
shift to a 8–10 Hz phasic firing mode, which differentially regulates downstream circuit processing13,14. NA release 
in targets therefore depends on the firing pattern of NALC cells, which is modulated by many afferents. One of 
the densest innervation originates from HCRT neurons9,15–17. HCRT cell activity is enhanced by a wide range 
of behaviorally relevant stimuli, and was demonstrated to drive HCRT release in the LC, and to increase NALC 
neuron firing rate, both in slices16,18,19 and behaving animals20. HCRT in the LC, in turn was shown to evoke NA 
release in the dentate gyrus21, and the prefrontal cortex (PFC)22,23. How much of the LC response to salient cues 
reflects a primary response of HCRT neurons to these cues, remains unclear.
HCRT acts by signaling through two G-protein-coupled receptors, HCRTR1 and HCRTR224, which are dif-
ferentially expressed throughout the brain. In situ hybridization reveals that the LC, as well as the brainstem’s six 
other NA cell groups, express Hcrtr1, in relative absence of Hcrtr2 expression20,25,26.
Optogenetic stimulation of both HCRT and NALC neurons increases the probability of sleep-to-wake transi-
tions, but with much faster dynamics for NALC, than HCRT neurons27,28. NALC optogenetic inhibition concerted 
with HCRT cell stimulation represses, while co-stimulation enhances, awakening29, establishing the HCRT-LC 
connection as a critical circuit to transition from sleep to wake. Loss of HCRT signaling by disruption of Hcrt, 
both Hcrtr1 and Hcrtr2 genes, or ablation of HCRT-producing cells, profoundly alters behavioral state regulation, 
and closely phenocopies narcolepsy symptomatology30–32. Loss of NA by disruption of the gene encoding the 
NA-synthesizing enzyme, Dopamine-β-hydroxylase (Dbh), produced contradicting reports, with indication of 
normal33, or reduced34 wakefulness in mice, and reduced wakefulness in zebrafish35.
Here we use genetic tools to inactivate the functional connectivity between HCRT neurons and downstream 
NA neurons. We generated a novel CRE recombinase-dependent Hcrtr1 KO mouse strain, and we used a Dbh-Cre 
transgene36 to drive Cre expression in NA cells. In the resulting (Hcrtr1Dbh-CKO) mice, Dbh-expressing cells 
undergo Cre-mediated deletion of an essential Hcrtr1 gene fragment, thus abolishing HCRTR1 signaling in all 
brain NA circuits. As HCRTR1 is thought to get transported to the NA cell membrane in the soma, the dendrites, 
and the axonal terminals, our mutant mice’ NA neurons lose the ability to respond both postsynaptically to HCRT 
(whithin NA cell groups), and presynaptically (within target tissues). Indeed NA release is finely regulated at the 
level of NA terminals, not only by autoinhibitory α2-adrenoceptors, but also by dopamine and other presynaptic 
receptors37,38. HCRTR1 was reported to act presynaptically at a variety of brain sites, regulating the release of 
glutamate, GABA or Ach39–47. Whether HCRTR1 acts presynaptically at NA terminals has, to our knowledge, not 
yet been investigated.
As HCRTR1 modulates behavioral arousal induced by both aversive and appetitive stimuli8, we assessed the 
global impact of the loss of HCRT-to-NA signaling by measuring brain oscillatory dynamics of Hcrtr1Dbh-CKO 
and control mice as they freely behaved in environments of both negative and positive emotional valence. Loss 
of HCRT-to-NA signaling was found to primarily affect the main ECoG correlates of arousal, i.e. θ and fast-γ 
frequencies. In stress-associated conditions, Hcrtr1Dbh-CKO mice’ waking exhibited increased δ and inter-δ/θ 
(4–7 Hz) activity, suggestive of reduced alertness, while normal induction of θ and fast-γ oscillations was blunted. 
Surprisingly, in spontaneous nocturnal nestbuilding-associated wake which precedes sleep, Hcrtr1Dbh-CKO mice 
displayed higher θ and fast-γ activity. Our study evidences the role of HCRT-to-NA signaling in building an 
appropriate θ/fast–γ response in stressing environments, and reveals circumstances in which HCRT-to-NA sign-
aling may serve to curb hyperarousal.
An earlier version of this report was published on bioRxiv48.
Results
Generation of a Cre-dependent Hcrtr1 KO mouse strain, and selective Hcrtr1 gene inactiva-
tion in NA neurons. We modified Hcrtr1 in embryonic stem cells so that the gene gets fully inactivated in 
presence of CRE, but remains functional in its absence (Fig. 1a). We inserted two loxP sites to flank an essen-
tial N-terminal-encoding region, and further modified the Hcrtr1 locus so that CRE-mediated loxP site-specific 
recombination has three main effects: (1) it excises exons 3 and 4, which encode the signal and N-terminal pol-
ypeptide up to within transmembrane domain 3 (a total of 126 aa), (2) it replaces the Hcrtr1 open reading frame 
with a (promoterless) Gfp open reading frame, allowing to use GFP expression to monitor cells which have under-
gone Hcrtr1 gene disruption, but have an active Hcrtr1 promoter, and thus would normally express Hcrtr1, and 
(3) it inserts a polyadenylation signal downstream of the GFP cassette, and thus terminates transcription and pre-
cludes expression of downstream exons. This conditional KO (CKO, or ‘floxed’) allele is referred to as Hcrtr1flox.
To generate NA-specific Hcrtr1 deficient mice, Hcrtr1flox/flox mice were crossed with mice harboring a 
Dbh-Cre BAC transgene36. We established breeding pairs that generate two offspring groups: Hcrtr1flox/flox; 
Methods). The size indicated above scale bars in (b) applies also to (c–f). Mouse Genome Informatics: Hcrtr1flox 
is Hcrtr1tm1.1Ava (MGI:5637400), and Hcrtr1KO-Gfp is Hcrtr1tm1.2Ava (MGI: 5637401) (www.informatics.jax.org/
reference/j:226158 50).
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TgDbh-Cre-positive (Hcrtr1Dbh-CKO, or CKO) mice, and Hcrtr1flox/flox; TgDbh-Cre-negative (Hcrtr1Dbh-CTR, or CTR) 
mice. All analyses rely on pair-wise comparison between these two groups.
To demonstrate that accurate Cre-dependent DNA recombination occurs at the Hcrtr1 locus, we prepared 
tissue punches from various tissues and brain areas from CKO and CTR mice, and the Hcrtr1 gene was analyzed 
and sequenced. Only genomic DNA from the LC area of CKO mice amplified diagnostic recombined fragments 
of the Hcrtr1 gene, whose sequencing confirmed accurate genomic structure and inter-loxP deletion breakpoints 
(see Methods).
GFP labeling of NALC cells in Hcrtr1Dbh-CKO, but not Hcrtr1Dbh-CTR mice, evidences Hcrtr1-to-Gfp 
open reading frame replacement. We first evaluated how efficient and specific the Dbh-Cre trans-
gene used to target NA neurons was, by comparing tyrosine hydroxylase (TH) and CRE immunofluorescence 
in LC sections from CKO mice. Out of 732 TH-immunoreactive neurons, 689 expressed CRE (94.3 ± 2.1%, 
mean ± SEM for n = 3 mice; Fig. 1b,g). Conversely, 96.8 ± 1.4% of CRE-positive cells also expressed TH, con-
firming high penetrance and specificity of the transgene, respectively. Next, to determine efficiency and specificity 
of CRE-mediated recombination at the Hcrtr1flox locus, LC sections were assayed for TH and GFP co-expression. 
This revealed bright GFP immunoreactivity in NALC cells of CKO mice (Fig. 1c), and its absence in CTR mice 
(Fig. 1d). Out of 674 TH-positive cells in LC of CKO mice, 658 co-expressed GFP (97.6 ± 1.3%, n = 3; Fig. 1h), 
hence had undergone CRE/loxP recombination, while among 710 GFP-positive cells, 92.9 ± 2.4% co-expressed 
TH, indicating, respectively, high penetrance and specificity of genomic deletion at the Hcrtr1flox locus.
Loss of HCRTR1 immunoreactivity. To further demonstrate that genomic deletion precludes HCRTR1 
protein expression, we assessed LC sections of CKO and CTR mice for TH and HCRTR1 immunofluorescence 
(Fig. 1e,f,i and see Methods). Among 523 TH-positive cells in the LC of CTR mice, 498 were positive for HCRTR1 
(93.3 ± 3.7%, mean ± SEM for n = 4 mice; Fig. 1f,i), while among 431 TH-positive cells in LC of CKO mice, only 
11 were HCRTR1-positive (2.8 ± 2.0%, n = 3; Fig. 1e,i). Consistently with the NA-cell specificity of Hcrtr1 dis-
ruption, HCRTR1-immunoreactive, TH-negative cells were present in brain areas outside the LC (Fig. 1e). These 
data demonstrate highly penetrant, Cre-dependent Hcrtr1 KO in the LC TH+ neurons of our CKO mouse model.
To further validate our Hcrtr1 mutagenesis strategy, we generated mice carrying the recombined (KO-Gfp) 
Hcrtr1 allele (Fig. 1a) in all cells. To this end we crossed Hcrtr1flox/flox animals to EIIa-Cre transgenic mice49, a 
line expressing CRE in the pre-implantation embryo (see Methods). Early embryonic CRE/loxP recombination 
allowed transmission of the recombined Hcrtr1 gene into the germ-line, creating a Hcrtr1KO-Gfp mouse strain. 
Homozygosity of the mutation is expected to provide a Hcrtr1 null. Furthermore, since Gfp is under control 
of the endogenous Hcrtr1 promoter, heterozygous Hcrtr1+/KO-Gfp animals permit mapping of Hcrtr1 gene activ-
ity across the organism50. As expected, nearly all TH+ cells in the LC of Hcrtr1+/KO-Gfp mice express GFP (see 
Supplementary Fig. S1a). Out of 709 TH-expressing cells (n = 3 mice), 99.6 ± 0.3% also expressed GFP, and 
91.2 ± 4.6% of GFP-positive cells in the LC also expressed TH, confirming the robust activity of the Hcrtr1 pro-
moter in NALC cells.
We next analyzed HCRTR1 immunofluorescence in mice heterozygous (n = 3), or homozygous (n = 3) 
for the Hcrtr1KO-Gfp mutation. LC imaging confirmed loss of HCRTR1 immunofluorescence in homozygous 
Hcrtr1KO-Gfp/KO-Gfp mice (Fig. S1b,c). In contrast to CKO mice, the latter mice have lost HCRTR1-immunoreactivity 
not only in LC TH+ cells, but in areas surrounding the LC as well (Fig. S1c). These data support the specificity of 
the antibody used in Fig. 1e,f to assess CKO and CTR mice, and creation of a constitutive Hcrtr1 KO (null) mouse 
model.
Increased δ oscillatory activity in wakefulness of Hcrtr1Dbh-CKO mice. A cohort of CKO (n = 9) 
and CTR (n = 7) animals were submitted to several behavioral paradigms across a 9-day period (Fig. 2) as their 
ECoG/EMG signals were recorded. In undisturbed conditions (baseline), total time spent in wakefulness (W), 
Figure 2. Experimental design. A cohort of Hcrtr1Dbh-CKO (n = 9) and Hcrtr1Dbh-CTR (n = 7) littermate mice 
were sequentially exposed to distinct behavioral paradigms, as their ECoG was recorded. Spontaneous waking 
ECoG activity was analyzed in the first two baseline (BL) days. Starting at light onset (ZT0) of day 3, mice were 
submitted to total sleep deprivation for 6 hours (6 h) in their home cage (EW or enforced waking). Mice were 
then left undisturbed for two days. At dark onset (ZT12) of day6, nest material was introduced (+Nestlet), and 
the waking ECoG analyzed in the following 24 h. After an additional two intervening days, 3 h after light onset 
(ZT3) of day 9, each mouse was removed from its nesting cage, and transferred to a fresh cage (cage change, 
CC). CC-induced waking was analyzed until the next SWS-onset. Shaded areas represent the 12 h dark phases.
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Figure 3. Spontaneous vs. enforced wakefulness. (a) Mean (±SEM) hourly values of (Top) total waking 
time [min/h], (Middle) theta-dominated-waking (TDW) [min/h], and (Bottom) locomotor activity (LMA) 
[counts/h] across experimental days 1–3 in Hcrtr1Dbh-CKO (CKO, black round symbols), and Hcrtr1Dbh-CTR (CTR, 
grey round symbols) mice. ECoG spectra are shown for: (b) wakefulness in baseline dark phase ZT12–18, (c) 
TDW in baseline dark phase ZT12–18, and (e) enforced waking ZT0–6. ECoG power density is expressed as % 
of a baseline power reference value, calculated for each mouse across all states and all frequencies over 48 h135 
(see Methods) [% of ‘BL total power’]. Note non-linear axes. Insets in (b and e) show ECoG spectra magnified 
across frequency ranges of interest, depicted with linear axes. Waking spectra of CKO mice differed significantly 
from those of CTR mice in all 3 cases (b,c,e). Spectra depicted in b and e demonstrate significant genotype, 
and genotype X frequency effects across 0.75–80 Hz (two-way ANOVA, P < 0.001 for all). Baseline TDW 
(c) demonstrates a significant genotype effect (two-way ANOVA, P < 0.001), with no genotype X frequency 
interaction (P = 0.249). CKO mice’ baseline waking showed enrichment in frequencies in the δ range (1.25 to 
2.75 Hz) relative to CTR littermates (b). During EW (e), CKO’ ECoG power increase extended to encompass 
the 1.5–6.75 Hz (δ + inter-δ/θ), and 13.5–24 Hz (β) frequency ranges (post-hoc independent two-tailed student 
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slow-wave-sleep (SWS), or paradoxical sleep (PS), and their temporal dynamics over the 24-h day did not differ 
between the two genotypes (Figs 3a, S2, S6, and Supplementary Table S1). To assess the finer architecture of 
sleep-wake states, we quantified the distribution of episode duration, both with respect to episode number as well 
as the percentage of total time in each state spent in episodes of various durations (Figs S2 and S3). Sleep-wake 
architecture was very similar for the two genotypes with the exception of PS. For this state we observed a right 
shift of the distribution of percent time spent in PS across episode duration categories (Fig. S2b Right; interaction 
for factors ‘episode duration’ and ‘genotype’ two-way ANOVA, P < 0.002), with CKO mice spending most of PS in 
~2-min bouts (64–128 s), while CTR mice spent most of PS in ~1-min bouts (32–64 s).
Furthermore, during the 18 h for which recovery sleep was monitored after the 6-h sleep deprivation, hourly 
sleep-wake state amounts did not differ between the two genotypes (Figs 3a and S6), again with the exception 
of PS (Fig. S2a). The timecourse of hourly values of PS time was significantly altered by genotype (interaction 
factors ‘time’ and ‘genotype’ two-way ANOVA, P = 0.01). CKO mice spent significantly more time in PS than did 
CTR mice in the middle of the recovery light period [ZT8–10], which is the period of maximal PS rebound for 
both genotypes. In that interval, CKO expressed a 26% increase in PS time over CTR mice (CKO: 14.4 ± 0.5 min 
vs CTR: 11.4 ± 0.4 min; t-test p = 0.0005), which was due to a 20-s lengthening of mean PS episode duration 
(+31%) (CKO: 84.7 ± 5.6 s vs CTR: 64.9 ± 4.1 s; t-test, P = 0.018), leaving episode number unaffected (−5%; 
t-test, p = 0.691). Altogether these data suggest that PS maintenance, but not initiation, is favoured in CKO mice. 
An increase in PS state stability in CKO mice may be related to the known PS-suppressing activity of the HCRT-1 
peptide, as demonstrated when locally applied in LC of rats20.
While the duration of CKO mice’ baseline waking was unchanged, its spectral quality was. Spontaneous wake-
fulness of CKO mice showed increased ECoG activity within the δ frequency-range (1.25 to 2.75 Hz) relative to 
CTR littermates in the dark phase first 6 h (ZT12–18) (Fig. 3b). To delineate the times of day in which CKO mice’ 
wake differs in spectral activity, the power dynamics of the waking ECoG in specific frequency bands were plot-
ted across days 1–3 using the same power reference as used in the waking spectra of Fig. 3b (see Methods). This 
revealed that CKO mice’ waking state is enriched in δ frequencies throughout recording days 1–3, but particularly 
at times of increased behavioral activity (i.e., in dark phase and during EW; Fig. 3d Bottom). It thus appears that at 
critical times of enhanced arousal, CKO mice are impaired in reducing δ activity as normal mice do. Heightened δ 
activity while awake is associated with drowsiness and increase sleep pressure in rodents and humans51,52.
We then asked whether the enhanced waking δ activity of CKO mice could also be observed during active 
waking, or more specifically in the ‘theta-dominated waking substate’ (TDW), we previously formulated an 
ECoG-based algorithm to identify53. We found that CKO mice’ baseline TDW state features increased power in 
the δ range (2.0–3.0 Hz) relative to CTR mice as well (Fig. 3c). Further analysis revealed that increased δ power 
also affects CKO mice’ non-TDW waking (akin to ‘quiet waking’, not shown). Therefore the weakened ability of 
CKO mice to downregulate δ oscillations across waking substates suggests they suffer a globally reduced level of 
alertness.
Enhanced infra-θ oscillatory activity, and impaired θ and fast-γ power induction in enforced 
wakefulness of Hcrtr1Dbh-CKO mice. At light onset (ZT0) of day 3, when sleep propensity is maximal, an 
experimenter entered the room, and the gentle handling sleep deprivation procedure was initiated and main-
tained for 6 h. CKO mice’ ECoG spectra differed more extensively from CTR mice spectra in EW than they did 
in baseline waking (Fig. 3e). ECoG power across 1.5 to 6.75 Hz, encompassing δ and some of the traditionally 
defined θ range, and across 13.5 to 24 Hz (β) frequencies were enhanced in CKO mice. A prominent component 
of this activity increase occurs in the 4.0–7.0 Hz window, i.e., above the δ range but below the θ rhythm charac-
teristic of explorative locomotion and voluntary behaviors in rodents54. We refer to the 4.0–7.0 Hz range in mice 
as the ‘inter-δ/θ’ band (although it is sometimes included within the ‘θ’ window by others55. We reserve ‘θ’ for the 
higher-frequency (7.5–11.5 Hz), narrow-bandwidth, hippocampal oscillations that are specifically induced upon 
active waking, and define the TDW state53. In contrast, the 4.0–7.0 Hz activity (see peak in baseline waking ECoG 
spectra, Fig. 3b) dominates during quiet waking and automatic behaviors, and it increases as sleep homeostatic 
pressure rises51,55.
Next, we examined the dynamics of the two other oscillatory ranges associated with reduced arousal (inter-δ/θ, 
and β) (Fig. 3d). Throughout the three days, CKO mice exhibited higher δ, but also inter-δ/θ, and, to a lesser 
degree, β (15–30 Hz) activity, compared to CTRs. Interestingly, CKO mice exhibited a steep power increase in all 
three bands in the course of EW, while this was not the case in control mice. This again indicates that CKO mice 
have an impaired ability to repress infra-θ oscillations at times of enhanced arousal, and furthermore suggests a 
faster build up rate of electrocortical signs of sleep pressure.
t-tests, P < 0.05). Inset in e shows the theta rhythm’s peak frequency (TPF) during EW in CKO (black round 
symbol), and CTR (grey round symbol) mice (mean ± SEM). TPF is slower in CKO mice (two-tailed t-test, 
P < 0.05, red asterisk). (f) To extract the spectral traits specific to the EW response within each genotype, EW 
power spectra are expressed relative to baseline waking power spectra (as averaged across 48 h in recording  
days 1–2). EW/baseline power density ratio is expressed as log2 with 0 indicating no change and ±1.0 indicating 
a 2-fold change. CKO mice’ EW-response is marked by a lesser increase in the θ range (bins concerned: 8.75–
9.5 Hz) and a lesser decrease in the δ and inter-δ/θ ranges (bins concerned 1.75–3 Hz and 4.5–7 Hz).  
(d) Timecourses of waking δ (1–4 Hz), inter-δ/θ (4–7 Hz), and β (15–30 Hz) activity during days 1–3, expressed 
as % of the same baseline total ECoG power reference as used for the waking spectra in b-c and e. Red bars 
indicate significant genotype differences (post-hoc independent two-tailed student t-tests that followed two-
way ANOVAs, P < 0.05).
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Figure 4. Hcrtr1Dbh-CKO mice exhibit weakened θ and fast-γ activity responses during gentle handling-enforced 
wakefulness (EW). (a) Heatmap depicting the ECoG spectral dynamics of the waking state across days 1–3. 
ECoG power in each 0.25 Hz frequency bin is expressed as % of its average value in the last 4 h of the light 
phase (ZT8–12) in baseline days 1–2. Values are color-coded according to the scale shown on the right. (b) 
Differential dynamics of the waking ECoG of CKO and CTR mice (CKO-CTR). Spectral dynamics shown in (a) 
were substracted from each other [Δ%]. While both CKO and CTR mice’ waking state exhibit sharp increases 
in θ and fast-γ activity during EW (a), CKO mice’ waking exhibits a markedly lower θ, as well as fast-γ power, 
relative to CTR mice during EW, in particular in the first hour (dark blue), and a concomitant increase in infra-θ 
power. Episodes in which CKO-CTR differential activity shows, inversely, higher θ and fast-γ, power in CKO, 
occur during spontaneous waking, in particular in the dark phase, at times of high wakefulness (see Fig. 3a), 
during both baseline and recovery night. Such particularly pronounced episodes appear to occur during 
the recovery night after EW. White lines delimit areas in which power density significantly differs between 
genotypes (two-tailed t-tests, P = 0.05). Note that color scales in (a and b) differ. (c) Timecourses of the waking 
ECoG activity in the δ (1–4 Hz) and inter-δ/θ (4–7 Hz) frequency bands across 6-h of EW, are depicted, with 
power expressed, as in (a), as % of its mean value in baseline ZT8–12 wakefulness.
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Figure 5. Hcrtr1Dbh-CKO (CKO) mice display weakened θ and fast-γ oscillatory responses upon transfer from 
their nesting cage to a clean cage. Mice were transferred to a fresh cage at ZT3 of the 9th recording day. (a) Mean 
(±SEM) hourly values of (Top) total waking time [min/h], (Middle) theta-dominated-waking (TDW) [min/h], 
and (Bottom) locomotor activity (LMA) [counts/h] in the day preceding, and the day in which cage change 
(CC) occurred in CKO and CTR mice. (b) Latencies to SWS-onset are calculated as the time between CC 
and the first SWS episode [minute]. (c) Waking ECoG spectra from CC to SWS-onset in Hcrtr1Dbh-CKO (CKO, 
n = 8), and Hcrtr1Dbh-CTR (CTR, n = 6) mice, with power density values, expressed as % of each animal’s baseline 
ECoG ‘total power’ reference, as for spectra shown in Fig. 3b,c,e. Note the non-linear axes. CC-induced waking 
spectra of CKO and CTR mice differed, demonstrating significant genotype, and genotype X frequency effects 
across 0.75–80 Hz (two-way ANOVA, P < 0.001 for all). CC induces a θ oscillatory peak in both genotypes, 
but its shape appears blunted in CKO mice. (d) To next extract CKO and CTR mice’ CC-induced changes in 
spectral oscillatory activity, CC-induced power spectra (as shown in c) were expressed relative to the mice’ 
baseline waking spectra (as averaged across the preceding 24 h period) (CC-induced/Baseline waking). Power 
density ratio is expressed as log2. CKO mice exhibit a lesser decrease in inter-δ/θ band activity, and a profoundly 
diminished 53–80 Hz (fast-γ) response compared to controls (two way ANOVA indicated significant genotype 
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In both CKO and CTR mice, EW is singularized from average baseline waking by emergence of a sharp θ 
rhythm (Figs 3e and 4a). EW in CKO mice however differed from CTR mice’ EW in θ frequency and power. In 
CKO mice, the θ rhythm was significantly slower (Fig. 3e inset; CKO vs. CTR, 8.1 ± 0.1 Hz vs. 8.6 ± 0.1 Hz; t-test; 
t14 = −3.749; P = 0.0022; and see Supplementary Table S2). To extract the spectral features of each genotype’s 
EW-response, EW spectra were contrasted to baseline waking spectra (Fig. 3f). This revealed that the increased θ, 
and decreased inter-δ/θ activity, that characterize the CTR mice’ response during the gentle-handling procedure, 
were significantly diminished in CKO mice. Lower activity in the θ range, but higher infra-θ (δ and inter-δ/θ) 
activity mark the blunted EW θ response of CKO mice, and both are suggestive of a weaker medial septal/hip-
pocampal activation56.
Robust θ oscillations and TDW expression characterize vigorous explorative locomotor activity (LMA), but 
can also uncouple from it53, and be observed in immobile rats following a running bout57, or in association with 
motivational activation58. To investigate this relation in our mutant, LMA was monitored. While LMA was nor-
mal throughout the two baseline days, its increase during the 6-h EW period was markedly reduced in CKO mice 
(Fig. 3a Bottom; CKO vs. CTR, 929 ± 120 vs. 1631 ± 190 counts; Mann-Whitney U test, P = 0.01). We previously 
found that mice lacking all HCRT signalling (Hcrtko/ko) exhibit reduced locomotion relative to WT littermates 
throughout baseline and EW53, with a reduction during EW that was very similar in extent to the one we observe 
here in CKO mice relative to their CTR littermates. This suggests that the role of HCRT in locomotion relies pri-
marily on the HCRT-to-NA pathway in EW, but on other HCRT targets in spontaneous waking.
To investigate more globally the spectral dynamics of wakefulness, an ECoG power heatmap was generated as 
a function of frequency and time, across the entire 0.75–90 Hz spectral range, and days 1–3 (Fig. 4a). As waking 
spectra show a strong dependence on prior sleep/wake history and homeostatic sleep pressure, the waking ECoG 
was referenced to baseline light phase last 4 h, i.e., after the major sleep period, when sleep pressure has returned 
to trough values (see Methods, Fig. 4 legend, and Fig. S4). This analysis revealed in both CKO and CTR mice 
powerful θ and fast-γ activity surges occurring in concert during EW, as well as, but to a lesser degree, in baseline 
waking of the first half of the dark period (Fig. 4a).
To next specifically delineate the genotype-based differences in this response, the two spectral dynamics 
obtained in Fig. 4a were subtracted from each other to produce the CKO-CTR differential profile in waking ECoG 
dynamics shown in Fig. 4b. This reveals a number of genotype differences. CKO mice feature a prominent deficit 
in enhancing θ oscillations during EW (blue color-code in b). θ oscillatory power induction, bandwidth narrow-
ing, and frequency increase that characterized CTR EW are all weakened in CKO mice. Furthermore, a 70–90 Hz 
activity, closely paralleling θ power dynamics, was found to surge during EW, and to be similarly weakened in 
CKO mice. This is in line with the reduced θ power response of CKO mice in EW, as observed by spectral analysis 
in Fig. 3f. Surprisingly, some time intervals in the active (dark) phase, conversely, appeared to be associated with 
enhanced θ activity in CKO relative to CTR mice (Fig. 4b), a finding further replicated, and extensively discussed, 
below. Analysis of the dynamics of δ (1–4 Hz) and inter-δ/θ band (4–7 Hz) oscillatory power throughout EW 6-h 
revealed enhanced δ, and inter-δ/θ activity in CKO mice, in particular in EW’ 2nd half (Fig. 4c), a finding consist-
ent with EW spectral profiles (Fig. 3e,f). Altogether our data suggest that the hippocampal θ and fast-γ oscillatory 
responses to EW are blunted in CKO mice. Hence we propose that HCRTR1-dependent neuromodulation of NA 
microcircuits contribute significantly to these responses.
Hcrtr1Dbh-CKO mice exhibit weakened θ and fast-γ oscillatory responses to cage change. 
Following EW and recovery period, mice were left undisturbed for 2 days. At dark onset of day6, each mouse was 
provided nesting material, and left undisturbed for another 2 days (see next section). To assay capacity to adapt 
to a new environment, mice were transferred from their nesting home cage to a clean cage at ZT3 (see Fig. 2), a 
time ordinarily spent predominantly asleep (Fig. S6). Cage change (CC) had a powerful arousing effect lasting 
between 1.5–2 h in both genotypes, (Fig. 5a Top). The ECoG response to CC however differed between the two 
groups (Fig. 5c). An active waking-like θ activity peak emerges in both mouse groups, but it appears blunted in 
CKO mice.
When waking spectra were analyzed specifically for their CC-induced features, (by plotting power spectral 
density values following CC relative to each group’s own average baseline values (Fig. 5d), and CC responses 
were contrasted between the two genotypes, CKO mice were seen to exhibit (i) a lesser CC-induced reduction in 
inter-δ/θ activity, similar to what was observed in EW (Fig. 3f), and (ii) a profoundly diminished fast-γ response 
across 55 to 80 Hz.
Heatmap representations of the spectral dynamics of the waking state expressed from CC to the subsequent 
SWS-onset (Fig. 5e), and the differential CKO-CTR dynamics thereof (Fig. 5f), confirm the weakened ECoG 
response of CKO mice. They powerfully illustrate CKO mice’ blunted θ rhythm response, compared to CTR mice’ 
and genotype X frequency effects, P < 0.001 for both). Red bars indicate significant genotype differences (post-
hoc independent two-tailed t-test). (e) Spectral dynamics of the waking ECoG after cage change, across time 
(from ZT3 to SWS-onset), frequencies (0.75–90.0 Hz), and power (expressed as % of each mouse’ mean waking 
ECoG power in that frequency bin in the preceding day’s ZT8–12 time interval; color-coded as shown on the 
right. x-axis shows ZT time, adjusted to individual waking latencies to SWS-onset. (f) The differential CKO-
CTR waking power dynamics following CC are depicted as they were for EW (Fig. 4b). Note that color codes 
for (e and f) differ. (g) Timecourses of ECoG power in two infra-θ frequency bands (1–4 Hz; 4–7 Hz) that were 
seen to respond in CC-induced waking in (e,f). ECoG power is expressed relative to the power in that band 
in average preceding day wakefulness. Red squares indicate time intervals in which ECoG power significantly 
differed between CKO and CTR mice (independent two-tailed student t-test, P < 0.05).
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Figure 6. Availability of nesting material induces a stronger θ and fast-γ oscillatory response in Hcrtr1Dbh-CKO 
(CKO) mice than it does in control littermates in late night wakefulness that precedes sleep. Nest material (a 
NestletTM) was provided at dark onset (ZT12), and the ECoG was recorded in the following 24 h. (a) Mean 
(±SEM) hourly values of (Top) total waking time [min/h], (Middle) theta-dominated-waking (TDW) [min/h], 
and (Bottom) locomotor activity (LMA) [counts/h] across the night that followed Nestlet addition, and the 
following light phase. Red asterisks denote time intervals with significant genotype differences (t-test, P < 0.05) 
(b) ECoG power heatmaps depict the spectral dynamics of the waking state across the nesting night and the 
following light phase as shown in Fig. 4a. Plotted are ECoG power densities for each 0.25 Hz frequency bin 
relative to their values in baseline wakefulness across the ZT8–12 period [%]. (c) Differential CKO-CTR 
heatmap of the nesting 24 h period was constructed similarly to Fig. 4b. Note that the color code for (e and g) 
differ. (d) Waking ECoG spectra in the last 2 h (ZT22–24) of the nesting night are plotted as % of the baseline 
total power reference [%], as in Fig. 3b,c,e. CKO and CTR mice’ spectra demonstrate significant genotype, and 
www.nature.com/scientificreports/
1 1SCIentIfIC RePORTS |  (2018) 8:15474  | DOI:10.1038/s41598-018-33069-8
response, as well as CKO mice’ impaired inter-δ/θ band activity dampening relative to its value in preceding light 
phase last 4 h (Fig. 5e left, and 5f), while this CC-induced dampening is evident in controls (Fig. 5e right). CKO 
mice’ weakened fast-γ response is also clearly apparent (Fig. 5e,f).
Analysis of the dynamics of δ (1–4 Hz) and inter-δ/θ band (4–7 Hz) oscillatory power in CC-induced waking 
(Fig. 5g) revealed a rise in inter-δ/θ activity in both genotypes as time progresses. This increase was steeper how-
ever in CKOs, in particular in the 2nd hour (independent two-tailed student’s t-test, P < 0.05). In sum, although 
CC enhances θ synchrony and fast-γ oscillatory power in both CKO and CTR mice, weakening of both processes 
in CKO mice suggests HCRT-dependent noradrenergic activation participates in enhancing θ/fast-γ network 
activity in response to adverse environmental changes.
Inverse θ and fast-γ dynamics of Hcrtr1Dbh-CKO mice in nesting-associated waking compared 
to enforced, or CC-induced, waking. To next explore our mice’ response to a novel, but unthreatening 
behavioral context, animals were recorded in a nestbuilding paradigm. Nesting material is rewarding in labora-
tory mice, and induces nestbuilding, a remarkably robust behavior59,60. A square of shreddable compressed cotton 
adapted for mouse nestbuilding (NestletTM), which the mice had never experienced before, was introduced in the 
homecage at dark onset (ZT12) of day 6 (see Fig. 2). Nestlet-to-nest conversion was confirmed at next light onset 
in all animals (CKO n = 5; CTR n = 5) (see Methods).
Video-based behavioral analysis of a subset of mice (CKO n = 3; CTR n = 1) evidenced two major nest mate-
rial interactive periods during the night: an early-night ‘discovery phase’, with numerous, brief episodes in which 
mice explored/shortly manipulated the Nestlet, and a late-night phase with longer manipulating bouts, and sus-
tained nestbuilding (Fig. S5). Late-night bouts typically preceded SWS episodes. CKO mice spent more time 
awake than CTR mice in the time interval immediately preceding light onset (Fig. 6a).
The spectral dynamics of the waking state in the 24 h following Nestlet addition were first globally assessed in 
ECoG power heatmaps (Fig. 6b,c). This corroborated the existence of two nocturnal phases of heightened arousal, 
and, surprisingly, suggested that CKOs express a waking state higher in θ and fast-γ activity than do CTR litter-
mates in early night (ZT12–15), when Nestlet novelty is maximal, and again in the last 2 h of the night (ZT22–24), 
preceding sleep.
Because only the late-night phase was associated with sustained nestbuilding activity, we focused our spectral 
analysis on waking of the night’s last 2 h (ZT22–24, Fig. 6d,e). To extract the electrocortical features specifically 
set in place in response to the nesting condition, we contrasted the ECoG power density values in waking during 
ZT22–24 of the nesting night to those in baseline waking in the same circadian time window. This confirmed 
that, conversely to EW and CC-induced waking, CKO mice’ wakefulness in late-night exhibit enhanced θ, as 
well as enhanced fast-γ (50–80 Hz) activity, compared to CTR mice (compare Figs 3f to 5d and 6e). Enhanced θ 
and fast-γ power in late-night furthermore coincides with a higher waking content (min/h) relative to CTR mice 
(Fig. 6a), that video data suggest may be related to nestbuilding activity.
Nestbuilding-associated waking of CKO mice exhibited moreover enhanced β (15–30 Hz) relative to CTR 
mice (Fig. 6e), as had been observed in CKO mice’ EW (Fig. 3f), and enhanced slow-γ (30.25–40.75 Hz) power 
(Fig. 6c,e). Elevated β and slow-γ synchrony are observed in dopamine-depleted rodents, and Parkinson disease 
(PD) patients in correlations with movement disorders61,62.
Because enhanced locomotion is part of the active waking response, it was also examined in this nesting 
paradigm. Surprisingly, CKO mice’ enhanced θ and fast-γ oscillatory responses were not matched by enhanced 
LMA. CKOs exhibited diminished LMA compared to CTRs, in early and late night (Fig. 6a), possibly reflecting 
stationary position assumed for Nestlet exploration/nestbuilding.
In summary, two paradigms of enhanced arousal under stress (EW and CC), and one ethologically-relevant, 
rewarding behavioral context (presence of nesting material prior to sleep), are found to elicit altered waking 
electrocortical responses in CKO mice relative to CTR mice, with, respectively, diminished, or enhanced θ and 
fast-γ activity. Figure 7 summarizes quantitatively these differential dynamics in waking θ and fast-γ oscillations. 
Because we here address the behavioral context-dependence of the dynamics of waking spectra, ECoG power is 
expressed relative to the average baseline (ZT0–24) waking ECoG activity in each frequency band. Nocturnal 
nesting-associated activity, and diurnal threat-avoidance (during ‘gentle handling’), or anxiety-related exploration 
(after CC63 appear therefore to induce highly divergent modes of HCRT-to-NA circuit processing and network 
oscillatory activity. Our data moreover suggest that these divergent oscillatory modes may alternate in the course 
of a day. CKO mice exhibit, as mentioned earlier, spontaneous periods of θ and fast-γ-enriched wakefulness 
in baseline dark phase, and, in a particularly pronounced manner, during the recovery night that follows EW 
(Fig. 4b).
SWS following threat-associated arousal is selectively deficient in slow-δ frequencies in 
Hcrtr1Dbh-CKO mice. SWS quality critically depends on preceding wakefulness quality, in particular on time 
spent in θ– and fast-γ-rich wake (TDW)53. We previously showed that SWS δ power, a widely used marker of sleep 
homeostatic pressure, which is classically modeled as a function of prior sleep/wake history and increases with 
time spent awake64,65, fails to reflect prior time awake in Hcrtko/ko mice in baseline. We found that this is linked to 
genotype X frequency effects across 0.75–80 Hz (two-way ANOVA, P < 0.001 for all). (e) ZT22–24 waking 
spectra shown in (d) are contrasted to waking spectra at the same time of day in baseline. The resulting Nesting/
Baseline waking ECoG power density ratio demonstrates a significant genotype effect (two-way ANOVA, 
P < 0.001), but no genotype X frequency interaction (P = 1). Red bars indicate significant genotype differences 
(post-hoc independent two-tailed student t-test, P < 0.05).
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Figure 7. Bidirectional and context-dependent θ and fast-γ oscillatory responses of Hcrtr1Dbh-CKO (CKO) 
and Hcrtr1Dbh-CTR (CTR) mice in three paradigms of enhanced arousal, in adverse (EW, CC), or rewarding 
(NEST) environments. (a) Waking ECoG θ (7.5–11.5 Hz; Left), or fast-γ (55–80 Hz; Right) power is plotted 
across time in three behavioral paradigms: 6-h EW (ZT0–6; Top), from cage change (CC at ZT3) to sleep onset 
(Middle), or in the night following provision of a Nestlet at dark onset (ZT12; Bottom). Because we address 
the context-dependence of θ and fast-γ dynamics, ECoG power in each band is expressed as % of its average 
value in baseline waking (ZT0–24). For each time-interval, power values are calculated 0.25 Hz-frequency 
bin by 0.25 Hz-frequency bin (as in heatmaps of Figs 4–6), and then averaged across the respective frequency 
ranges. An equal number of artefact-free 4-s waking epochs contributed to each time-interval for each mouse. 
The following intervals are plotted: EW, 10 intervals spanning 6 h; CC, 10 intervals spanning ~2 h; Nest, 18 
intervals spanning 24 h (the first 13 are depicted). For each paradigm, two-way ANOVA for factors genotype 
and time revealed that θ power varies significantly with the animal’s genotype (EW and CC: P < 0.0001; Nest: 
P = 0.0025), and across time (P = 0.0001). While all time-intervals show the same θ power trend in a particular 
paradigm, significant genotype difference is found for two intervals (red squares, t-test P < 0.05). Two-way 
ANOVA also indicates a significant genotype effect on fast-γ power for CC (P < 0.0001), and Nest (P < 0.035), 
and a significant time effect on fast-γ power in all 3 conditions (P < 0.0001). Note how the dynamics of θ and 
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the fact that, while they spend a normal time awake, Hcrtko/ko mice’ time in TDW state is profoundly diminished 
relative to WT littermates, due to a reduced ability to sustain TDW for a prolonged time53. We further found that 
SWS following spontaneous waking is not only reduced in δ power in Hcrtko/ko mice, but also spectrally skewed, 
with a much more pronounced deficit in the slow-δ (δ1, 0.75–2.25 Hz) oscillatory component, than in the fast-δ 
(δ2, 2.50–4.25 Hz) range. The significance of distinct δ frequency ranges in SWS remains unclear, however a cor-
relation between SWS δ1 component and prior active wake and related potentiation events was reported in other 
studies as well66.
Unlike Hcrtko/ko mice, Hcrtr1Dbh-CKO mice spend a normal time in TDW in baseline. However their waking 
ECoG during EW and after CC is diminished in θ and fast-γ activity relative to controls. Thus we hypothesized 
that subsequent SWS may also be affected, and spectrally differ from controls. Hence we analyzed SWS of CKO 
and CTR mice in baseline and following the 3 behavioral paradigms they were exposed to. To best capture the 
entire range of the sleep homeostatic response before it dissipates65, we restricted our analysis on the first 20 min 
of SWS following: baseline light onset (Fig. 8a), EW (Fig. 8b), and CC (Fig. 8c), and differentially examined δ1 
and δ2 activity. This revealed that CKO mice exhibit a severe δ1 power deficit in SWS following EW (Fig. 8b), and 
after CC (Fig. 8c), while δ2 power remains essentially normal. Baseline SWS (Fig. 8a) in contrast did not show a 
significance δ1 power deficit. CKO mice’ SWS after EW and the nesting night was moreover enriched in β and 
slow-γ activity (Fig. 8b,d).
If CKO mice’ SWS δ1 deficit after stressful arousal is linked, in full or in part, to the θ and fast-γ power paucity 
of their preceding wake, through mechanisms similar to those operating in Hcrtko/ko mice’ baseline SWS, CKO 
mice’ SWS after nestbuilding-associated waking, which conversely exhibits enhanced θ and fast-γ power, would 
not be expected to show an altered spectral distribution with underrepresented δ1 frequencies. CKO mice’ SWS 
following the nesting night was found to lack any δ, or selective δ1, power deficit (Fig. 8d), in accordance with our 
hypothesis.
Dynamic analysis of the two SWS δ oscillatory ranges across days 1–3 (Fig. S6c), and 8–9 (Fig. S6d) revealed 
δ1 to be diminished in CKO mice at all times, but more profoundly so following periods of maximal arousal (EW, 
and CC; Fig. S6c,d Top). Altogether, our data suggest that (1) the HCRT-to-NA circuit is critical to mount normal 
θ and fast-γ responses to environmental contingencies, (2) the content in θ and fast-γ frequencies of the waking 
ECoG affects not only subsequent SWS δ power, but also its spectral distribution, (3) waking enriched in θ and 
fast-γ frequencies induces preferentially a low-frequency component of δ oscillations in subsequent SWS.
Discussion
The main finding of this study is that chronic inactivation of HCRT-to-NA cell signaling affects θ and fast-γ 
frequencies during waking, and their repercussions on subsequent slow-δ frequencies during SWS. θ and fast-γ 
oscillations are electrocortical markers of active wakefulness and motivated behaviors. These rhythms provide a 
temporal framework on which the timing of neuronal spikes can be measured and computed during execution 
of complex behaviors such as navigation67. The induction of these two markers of arousal were diminished in 
CKO mice relative to control littermates during EW and following CC, whereas the opposite was observed in 
nesting-associated wakefulness preceding sleep.
Scope of the Hcrtr1Dbh-CKO mouse model. In CKO mice, NA neurons lack HCRTR1 in their soma, den-
drites, as well as synaptic boutons. HCRT induces depolarization and increased firing rate of NALC cells16,18,20, 
suggesting that HCRTR1 is present on NALC cell bodies or proximal dendrites, in agreement with the intense 
Hcrtr1 in situ signal over the LC26. The present study confirms at cellular resolution that the Hcrtr1 gene promoter 
is active in NALC neurons, as intense GFP-immunofluorescence was present in 98% of LC TH+ cells of CKO mice. 
HCRT receptors can enhance neurotransmitter release through either postsynaptic, or presynaptic effects41–46,68, 
and CKO mice are expected to be deficient in HCRTR1 expression and signaling not only in the NA cell nuclei, 
but also in their target tissues, such as the hippocampus, PFC, amygdala, ventral tegmental area (VTA), and the 
olfactory bulb10,17. However, activity of HCRTR1 at the level of NA cell axon terminal membranes has, to our 
knowledge, not yet been formally described.
The downstream effectors of HCRTR1 are known to be multiple and context-dependent. HCRTR1 can act 
through a great variety of signaling cascades, to mediate short-term changes in ionic conductances, or long-term 
changes in neuronal circuitry24. As HCRT enhances NALC cell firing, we interpret CKO mice’ phenotype at first 
approximation as the result of widespread loss in HCRT-induced NA signalling. HCRTR1 deficiency may how-
ever alter many other functions of NA neurons, such as signalling through other receptors, release of other neuro-
transmitters69, synaptic plasticity70, or gene expression, all of which contributing to the global phenotype. Further 
electrophysiological and molecular analyses of our mice are needed to evaluate these effects.
fast-γ oscillatory activities evolve in concert. (b) Waking θ and fast-γ power responses in the two time intervals 
marked by red squares in (a) are plotted in the three behavioral paradigms as % of their respective mean power 
in baseline ZT0–24 waking. (Left) ECoG θ power varies significantly with genotype (P = 0.0129), and condition 
(P < 0.0001), and shows a significant genotype X condition interaction (P < 0.0003, two-way ANOVA). CKO 
mice exhibit a significantly lower θ oscillatory response relative to CTR mice in wake during EW and after 
CC, but a significantly higher θ oscillatory response following Nestlet addition (t-test P < 0.05, indicated by 
red asterisks). (Right) ECoG fast-γ power tends to vary with genotype (P = 0.0507), and varies significantly 
with condition (P < 0.0001), and shows a significant genotype X condition interaction (P = 0.0091, two-
way ANOVA). t-test indicates that CKO mice display a significantly reduced fast-γ power response after CC 
(P < 0.05).
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Slowing of the oscillatory profile of wakefulness. Total time spent awake was normal in CKO mice in 
baseline conditions. Thus, although awakening induced by optogenetic stimulation of HCRT neurons was shown 
to be blocked by the concomitant photoinhibition of NALC cells29, loss of HCRTR1 in NA cells of CKO mice did 
not diminish total baseline waking, bout number or duration. This discrepancy may have several causes. First, 
Figure 8. Slow-wave-sleep of Hcrtr1Dbh-CKO mice is deficient in slow-δ (δ1) oscillations following exposure 
to stressful stimuli. SWS ECoG spectra across 0.75–40.0 Hz are shown for the first 20 min of SWS (a) after 
light onset in baseline, (b) after EW, (c) after CC-induced waking, and (d) after light onset following the night 
in which nest material was provided. ECoG power is expressed as % of the same baseline reference as used 
for waking spectra of Figs 3b,c,e, 5c and 6d. Vertical guides delineate the two δ oscillatory subranges (δ1, 
0.75–2.25 Hz; δ2, 2.50–4.25 Hz). SWS spectra of CKO mice differed significantly from those of CTR mice in all 
4 conditions (a–d). Spectra depicted in a-c demonstrate significant genotype, and genotype X frequency effects 
across 0.75–40 Hz (two-way ANOVA, P < 0.02 for all). SWS after nestbuilding (d) demonstrates a significant 
genotype X frequency interaction effect (two-way ANOVA, P = 0.015), while factor genotype did not reach 
significance (P = 0.82). In the δ range, only SWS following EW and CC (b,c) exhibited significant differences 
in CKO mice (post-hoc t-test, P < 0.05), with in both cases a more profound deficit in δ1 power. No significant 
deficit in δ1 power in SWS following nestbuilding, or in baseline, were found. (e) Average SWS δ1 and δ2 activity 
in the 20 min intervals analyzed in (a–d) indicate that SWS δ1 activity is diminished only after EW and CC in 
CKO relative to CTR mice (red asterisks, t-tests, P < 0.05).
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whereas optogenetic manipulations acutely modulate neuronal activity, NA cells of CKO mice are thought to lose 
Hcrtr1 gene function at the time the Dbh-Cre transgene is first expressed, i.e. in mid-gestation36. Compensatory 
mechanisms set in place during development71 may partially rescue CKO mice’ wake by upregulating other 
arousal pathways. For instance, increases in histamine cell number were reported in both narcoleptic patients and 
mouse models72. To examine whether NALC cell-specific Hcrtr1 gene inactivation at an adult stage causes a more 
severe phenotype than the one we report in CKO mice, a Th-driven Cre-expressing viral vector may be injected 
in the LC of adult Hcrtr1flox/flox mice. Second, although under optogenetic settings the HCRT-to-NALC circuit 
critically mediates awakening, under physiological conditions, other HCRT targets may also elicit state transi-
tions, and the HCRT-to-NALC circuit may mostly be critical under specific alerting contexts that are not met in 
our baseline conditions, or not at a rate sufficiently high to alter total time awake. Next, in the above optogenetic 
study, and upon HCRT infusion in LC in vivo20, NALC cell activation and state transition may not only be caused 
by released HCRT binding HCRTR1 on NA cells, but also HCRTR1 on synaptic terminals of a third LC cell type, 
e.g. glutamatergic neurons73, thus enhancing glutamate release, NA cell firing, and thereby the probability of 
awakening. The latter mechanism would be preserved in CKO mice.
While CKO mice’ waking time was not changed, its ECoG spectral distribution was. Baseline waking was 
enriched in δ (1.25–2.75 Hz) frequencies, and upon EW and CC, in δ and inter-δ/θ frequencies, both of which 
reflect homeostatic sleep pressure in rodents and humans. Waking δ activity moreover correlates with declining 
cognitive performance during prolonged waking, and elevation of δ, θ/α, and β power, while γ power fades, 
correlate with subjective sleepiness55,74–81. Thus an increase in slow (infra-θ) oscillations in CKO mice suggests a 
less alert waking state, which appears to affect waking globally, as active waking (TDW) is also excessively δ-rich. 
Mechanistically, waking δ activity may stem from localized SWS network activity occurring in the brain of a 
globally awake, but sleepy, animal82.
Increased waking β and slow-γ activity. In times of enhanced arousal, such as during EW and nest-
building, CKO mice display enriched β, or β and slow-γ (~15–45 Hz) power. Dopamine-depleted rodents also 
exhibit increased β/slow-γ activity while performing particular tasks62,83. Whether alterations in dopaminergic 
transmission are also present in our mice, potentially resulting from diminished dopamine release from NALC 
cells69, or from downregulation of a HCRT-NALC-DAVTA circuit, deserves further investigation. Its associa-
tion with impaired motor control also merits further investigation. Pathological β oscillations are present in 
Parkinson’s patients, as an ‘antikinetic β band’ correlated with movement disorder61. Hcrt-KO mice also show 
enhanced β/slow-γ activity in the minute that precedes cataplexy, which is characterized by indices of both elec-
trocortical and behavioral arousal, with vigorous activity, including nestbuilding84. Dysregulated motor events 
can also directly precede cataplexy, supporting the hypothesis that our mice’ β/slow-γ-enriched wake is related 
to PD’ antikinetic rhythm. Furthermore, the increase of β/slow-γ frequencies associated with diminished θ we 
observe in periods of intense arousal aligns with observations in rats, in which LC activation caused a suppression 
of β/slow-γ (12–40 Hz) frequencies, while enhancing θ oscillations85. LC activation was suggested to mediate this 
effect by repressing inhibitory hippocampal interneurons, thus enhancing conditions for synaptic potentiation 
and learning.
Diminished induction of θ and fast-γ frequencies in threat-associated wakefulness. In stressful 
conditions, as experienced by the mice during sleep deprivation and following CC, CKO mice had a reduced 
ability to mount a normal arousal response, consisting of a sharp θ spectral peak associated with a fast-γ power 
surge. This observation aligns with numerous prior findings. Various types of stress are associated with activa-
tion of HCRT neurons8, and we previously showed that HCRT is essential to stabilize θ– and fast-γ (θ/fast-γ) –
enriched wakefulness in some environments53. The emergence of a narrow-bandwidth θ rhythm at the transition 
from quiet-to-active waking may involve a process enhancing or stabilizing θ oscillatory synchrony in hippocam-
pal or neocortical networks, and NALC activation indeed enhances θ power and resets θ synchronization in hip-
pocampus and neocortex86–88. It was recently proposed that a temporal relationship between LC neuron spiking, 
NA release, and the phase of θ and γ oscillations exists, and participates in the mechanisms through which the LC 
resets network activity and mediates attentional shift in response to salient stimuli, and by which it may also coor-
dinate off-line events of importance for learning and memory89. Our mouse model may add to this view the role 
of the input contributed by the HCRT-to-NALC pathway in modulating LC activity in distinct behavioral contexts. 
Our data are also consistent with in vitro90, and in vivo91 reports evidencing the role of HCRT in θ wave activ-
ity through action on the medial septum. Both NA92 and HCRT90 have excitatory activity on septal GABAergic 
parvalbumin-expressing (PV) neurons. These cells participate into septo-hippocampal GABAergic reciprocal 
circuits, that are thought to be critical to disinhibit and synchronize hippocampal principal cells, thus generating 
the θ–rhythm93,94. In the hippocampus, HCRT was also reported to regulate θ–associated plasticity by a presyn-
aptic mechanism involving NA synaptic terminals95. Thus our findings reinforce the evidence linking HCRT, NA 
and hippocampal θ oscillations. Behavioral investigation of NA- and hippocampus-dependent forms of learning 
and memory in CKO mice are needed to shed light on the functional correlates of our observations.
Although we do not have θ-γ phase coupling data, a salient finding of our study is the consistent association 
between θ and fast-γ dynamics. The hippocampal networks that implicate the PV neurons mentioned above were 
suggested to play a role in coupling the θ rhythm with γ (35–85 Hz) waves96–98. Thus PV cells may contribute to 
the processes by which NALC activity supports phase-coupled rhythms99, and their regulation by a HCRT input. 
In addition, NA is known to increase γ (30–60 Hz), and decrease δ activity when injected in the basal forebrain 
of rats, an effect thought to be mediated by a depolarizing activity on cholinergic neurons100. Basal forebrain 
cholinergic cells project cortically and their role on stress-induced, HCRT-dependent arousal and the oscillatory 
changes we observe in our mice merits further investigation.
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Inverted θ and fast-γ responses in nesting-associated vs. stress-associated wakefulness. The 
ECoG exhibits a sharp spectral peak at θ frequencies (8–10 Hz), and a concomitant rise in fast-γ power when mice 
engage in intensive voluntary behaviors, both in threat-avoiding, or reward-seeking conditions. We exposed CKO 
and CTR mice to both types of contexts. Gentle handling during EW, and CC both induce a threat-avoiding-like 
response63, while nest material induces vigorous nestbuilding, and is rewarding59. CKO mice exhibited abnormal 
electrocortical responses in both types of conditions, albeit in opposite directions. They showed lower θ and fast-γ 
activity than controls in enforced and CC-induced waking, but θ and fast-γ power was higher than controls in 
late-night nestbuilding-associated waking preceding sleep. What could explain these opposite responses?
While arousal induced by both aversive and appetitive stimuli engage high θ and fast-γ oscillatory activity, 
they likely use distinct neurocircuits. Both are however expected to be modulated by HCRTR1 signaling8. Our 
prior work has demonstrated that θ/fast-γ-enriched waking is differently regulated when waking is spontaneous, 
or enforced, and differently affected by HCRT deficiency53. Considering the high complexity of HCRTR1 neuro-
transmission at both the circuit and cellular levels, a multitude of factors may contribute to context-dependent 
modulation of θ and fast-γ oscillations. As a working hypothesis, we focus on fear- (amygdala), and reward- 
(VTA) related structures, which receive both direct projections from HCRT and NA cell groups101–103.
A serial HCRT-NALC-lateral amygdala (LA) circuit in which intra-LC HCRTR1 signaling features a key role was 
recently shown to be critical for formation, maintenance, and extinction of fear memory104–106. Blocking LC HCRTR1 
activity reduced, while upregulating HCRT signaling within the LC enhanced, freezing behavior, a readout of fear 
memory. Furthermore, inhibition of HCRTR1 signaling within the amygdala facilitated fear memory extinction107.
Therefore, loss of HCRTR1 at the level of NALC cell bodies, and/or at synaptic terminals in the amygdala, may con-
tribute in blunting the fear response of CKO mice. It may be relevant to note in this context that reduced amygdalar 
activity during aversive conditioning was reported in human narcolepsy108. CKO mice’ deficient θ and fast-γ oscilla-
tory response upon EW and CC may indicate a weakened alerting response to threat. This is consistent with the obser-
vation that CKO mice’ waking ECoG spectra during EW and after CC are markedly enriched in frequencies associated 
with diminished alertness and sleepiness (δ, inter-δ/θ and β/slow-γ), compared to CTRs. A reduced fear response may 
contribute, conversely, to CKO mice’ enhanced behavioral activation during the self-motivated activities mice spon-
taneously engage in nocturnally, or when nest material is provided, causing the increased waking time, and θ/fast-γ 
oscillatory response they express in late-night phase, which is rich in pre-sleep nestbuilding activity. Assessment of 
CKO mice’ fear response will however require more elaborate behavioral and physiological measures of fear.
Tests for impulsivity and risk-taking behavior may furthermore complement assessment of CKO mice fear 
response. Increased impulsivity, and patterns of disadvantageous decision making were reported in narco-
lepsy109,110. These traits were hypothesized to result from emotional blunting associated with HCRT deficiency. 
Thus, although increased sleepiness is a cardinal symptom of narcolepsy, other symptoms such as increased 
impulsivity, or binge-eating behavior, might suggest forms of hyperarousal110,111. An increased incidence of atten-
tion deficit hyperactivity disorder (ADHD) symptomatology is reported in narcolepsy112.
At the cellular, mechanistic level, the bidirectional θ/fast-γ response of our CKO mice may involve multiple 
NA cell signaling pathways. Again we focus on one example. In addition to promoting NA release from axonal 
terminals in target tissues, HCRT is also reported to trigger and potentiate NA secretion non-synaptically, from 
the somata and dendrites of NALC cells113,114, in a process that is HCRTR1-, and NMDA receptor-dependent113. 
Therefore HCRTR1 may not only modulate NA release in targets, but also in the LC. Because binding of locally 
secreted NA to NALC cell autoreceptors represses NALC activity115, somatodendritic secretion provides a neg-
ative feedback regulatory pathway by which HCRTR1 may inhibit LC activity. NA somatodendritic secretion 
was indeed suggested as a potential therapeutic target to depress the NALC hyperactivity that results from opioid 
withdrawal113,116. Because somatodendritic NA secretion has distinct properties compared to classical synaptic 
transmission, including delayed kinetics and a tight dependence on the frequency of the incoming stimulation117, 
it may be favored over the latter in some behavioral contexts, possibly contributing to the enhanced behavioral 
activation and θ/fast-γ response of CKO mice in nocturnal nesting conditions.
Chronic loss of HCRT-to-NA signaling does not cause overt cataplexy. HCRT deficiency is known 
to cause the life-long disease narcolepsy with cataplexy. Ample evidence in canine models implicated the NA 
system in the control of cataplexy, leading to the NA hypoactivity hypothesis of cataplexy118. In narcoleptic dogs, 
NA cells cease firing at the onset of cataplexy episodes and resume spiking at cataplexy offset119, suggesting NALC 
activity is critical to couple arousal with muscle tone. Burgess and Peever120 suggested that cataplexy is caused 
by loss of HCRT control of the NA system, which is dispensable for consciousness, but needed for its associa-
tion with muscle tone. Although a comprehensive video-based behavioral assessment of CKO mice is yet to be 
performed, these animals did not demonstrate obvious electrocortical, or behavioral evidence of cataplexy84, in 
concordance with more recent studies32,121.
HCRT-to-NA signaling deficiency affects the spectral quality of SWS. We found that SWS follow-
ing stressful wake is selectively deficient in slow-δ (δ1) power in CKO mice. This is reminiscent of our observation 
of a similar δ1 deficit in the SWS of Hcrtko/ko mice following spontaneous waking. The latter was associated with a 
profound deficit of Hcrtko/ko mice in expressing θ and fast-γ activity during baseline waking, due to a profoundly 
reduced ability to sustain spontaneously electrocortical arousal (the TDW state), as reflected by a much lower 
average TDW bout duration compared to controls53. Here, we show that CKO mice express a waking state glob-
ally reduced in θ/fast-γ activity under stressful conditions, although TDW episode duration is essentially normal 
(Fig. S3). Thus a deficit in δ1 activity is selectively observed in SWS subsequent to θ/fast-γ-power-impoverished 
waking. We have shown that time spent in θ/fast-γ-rich/TDW state was the key driver of the sleep homeostatic 
response, since its proxy SWS δ power was seen to correlate with prior time spent in TDW, rather than in all 
waking53.
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A dependency of SWS δ1 on prior waking θ/fast-γ activity is strengthened by our observation that CKO mice’ 
SWS after nesting-associated wake, which, inversely to EW and CC waking, exhibit enhanced θ/fast-γ activity 
relative to controls, shows normal δ1 power. Our findings are also in line with the report that recovery SWS of rats 
that were depleted from cortical NA show a similar selective δ1 deficit66. Moreover, cortical expression of a set of 
synaptic activity-related genes was found to be diminished in these rats during EW66, as we also found to be the 
case in Hcrtko/ko mice in baseline dark phase53.
Altogether these studies suggest that the δ1 component of SWS activity has a privileged homeostatic link 
with, and dependency upon, θ/fast-γ oscillatory activity in prior waking. θ/fast-γ-dependent potentiating events, 
or other plasticity changes within cortical circuits which get facilitated by HCRTR1-mediated noradrenergic 
signaling during waking, may be causally linked to δ1 oscillations in subsequent SWS122. Our study suggests 
that HCRTR1-dependent NA signaling contributes to the homeostatic weight of waking, in particular as it is 
reflected in δ1 power in ensuing SWS. This hypothetically predicts that SWS δ1 oscillations mediate a specific, yet 
unknown, function in SWS-associated recovery processes.
The relation between the slow-δ (δ1) component of SWS and the cortical slow (<1 Hz) oscillation of alter-
nating UP and DOWN states in cortical neurons123, is unclear. Whereas the slow oscillation was originally iden-
tified through intracellular recordings, δ1 is a Fourier–derived rhythmic component of the ECoG. Two features 
of δ1 nevertheless suggest that δ1 and the slow (<1 Hz) oscillation are distinct: (i) the latter is reported to peak 
at ~0.3 Hz, whereas our δ1 rhythm is distinctly faster (0.75–2.25 Hz); (ii) while we clearly document the wake/
sleep-dependent homeostatic regulation of δ1, whether the slow oscillation is under homeostatic regulation is 
controversial. Both early and recent EEG studies in humans have suggested that the oscillatory component below 
1 Hz is unresponding to sleep deprivation124,125, strengthening the hypothesis that the two rhythms have different 
origins. This important question warrants further studies.
PS state consolidation. Lastly, while CKO mice’ episode number, duration, and total time spent in waking 
or in SWS were normal in the conditions we tested, the mice exhibited a modest but significant increase in PS 
stability, resulting in a shift towards longer PS bouts. Both HCRT and NA are known to have PS-antagonizing 
activities. Inhibiting NA signaling enhances, while increasing NA represses, PS126. Narcoleptic patients show 
an increased propensity to express the PS state127, and the same is true for Hcrt deficient mice in some condi-
tions53,84,128. The direct administration of HCRT-1 peptide into the LC of rats was shown to cause a decrease in 
both PS episode number and duration20. In our mice, chronic NA cell HCRTR1 deficiency appeared to increase 
PS maintenance, but PS initiation was unchanged.
Conclusions
Brain processes that alter the generation or the stability of θ and fast-γ waves appear particularly active in pres-
ence of ethologically-relevant stimuli, of either repulsive or attractive valence, of importance for survival. These 
dynamics can result from neuromodulation of circuits by wake-promoting molecules, such as NA and HCRT, and 
their receptors. Many of the mechanisms, both at cell and circuit level through which these molecules act remain 
elusive. While HCRT is essential for state stability129, including stability of the θ/fast-γ-enriched TDW state53, 
we suggest that the HCRT-to-NA circuit is a context-dependent modulator of the different spectral domains in 
which brain networks can engage, and that differentially assist and organize brain operations in wake, and their 
processing in sleep.
The understanding of how HCRT neurotransmission affects noradrenergic function has clinical relevance 
beyond implications for narcolepsy and cataplexy, as HCRTR antagonists are being developed as novel thera-
peutic agents not only for insomnia, but also in several neuropsychiatric disorders, such as anxiety, depression, 
and various forms of hyperarousal, including cocaine-withdrawal-, and post-traumatic-stress-related hyper-
arousal130. Furthermore, HCRTR1 ability to modulate LC neuronal activity is providing a novel therapeuti-
cally relevant tool in several neurodegenerative disorders in which LC neuronal damage appears to be an early 
event131. Many remaining challenges exist for HCRTR antagonists’ use in clinics, in particular because of the 
pleiotropy of HCRT functions, affecting not only arousal, but also e.g. food uptake, motivation and mood. The 
bidirectional effects of Hcrtr1 disruption in the NA system we report warrant further studies also for these rea-
sons. Thus our mouse model, and others that similarly inactivate a specific neuromodulator receptor in selective 
cell populations, will contribute in dissecting the mechanisms by which these molecules shape brain states and 
behavior.
Methods
Hcrtr1 gene engineering: creation of a CRE-dependent conditional KO (Hcrtr1tm1.1Ava) allele. 
Targeting strategy. We inserted a 5′loxP site in the 5′ untranslated region of the first coding exon (exon 3 accord-
ing to132) of Hcrtr1, 27 bp downstream of exon 3’s splice acceptor site, and 12 bp upstream of the initiation codon. 
The 3′ loxP site was inserted midway in intron 4 as a loxP-Kozak-Gfp-rabbit globin p(A)-FRT-Neo-FRT cassette. 
The inter-loxP distance is 1.1 kb.
Mutagenesis. The targeting vector for homologous recombination (Fig. 1a) was built using plasmid artifi-
cial chromosome (PAC) RP23-12J1 (BACPAC Resources Center, Oakland, CA, USA) a PAC from a C57BL6/J 
genomic DNA library containing Hcrtr1. Homologous arms spanning in total 10.0 kb were synthesized by PCR 
amplification of PAC RP23-12J1 using LA Taq (Takara), and Accuprime High-Fidelity (invitrogen) DNA poly-
merases. The targeting vector was linearized and electroporated in IC1, an embryonic stem (ES) cell line derived 
from C57BL/6NTac mice (ingenious targeting laboratory, Ronkonkoma, NY, USA). Single colonies were screened 
by Southern blot analysis using probes external to the targeting vector in both 5′ and 3′, and a Gfp internal 
probe. Two ES cell clones having undergone correct recombination events were identified and injected into 
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BALB/cAnNHEW blastocysts. Resulting chimeras were mated to Tg(ACTFLPe)9205Dym transgenic mice133 to 
excise the FRT-neo-FRT cassette. The neo-excised final conditional KO allele, Hcrtr1tm1.1Ava (MGI: 5637400), is 
referred hereafter as Hcrtr1flox (http://www.informatics.jax.org/allele/MGI:5637400).
Generation of noradrenergic cell-specific Hcrtr1-KO (Hcrtr1Dbh-CKO) mice, and evidence of 
tissue-specific, Cre-dependent Hcrtr1flox allele recombination and genomic deletion. To inactivate 
Hcrtr1 in NA cells, transgenic Tg(Dbh-icre)1Gsc mice, which carry a PAC transgene with Dopamine-β-hydroxylase 
gene (Dbh) sequences driving Cre36, were mated with Hcrtr1flox mice. Two PCR assays flanking the loxP sites of 
Hcrtr1flox were designed to amplify a diagnostic fragment of the recombined allele, and a 1.1 kb larger fragment 
(inter-loxP distance) from the unrecombined allele. Genomic DNA was prepared from tissue punches made in brain 
slices containing the LC, or other brain areas. Genomic DNA from the LC area of Hcrtr1Dbh-CKO mice amplified the 
diagnostic recombined fragments, but not from the LC of Hcrtr1Dbh-CTR littermates, neither from neocortex, or ear 
tissue of either CKO or CTR mice. CKO mice’ PCR products were gel purified and sequenced in both orientations, 
confirming accurate recombination at the nucleotide level in 2 Hcrtr1Dbh-CKO animals.
Generation of Hcrtr1 KO/GFP-reporter (Hcrtr1tm1.2Ava) mice. Hcrtr1flox/flox mice were mated to 
Tg(EIIa-cre)C5379Lmgd transgenic mice49, which express Cre at embryonic preimplantation stages. Offspring 
that stably transmitted the recombined (Hcrtr1tm1.2Ava) allele were selected for further breeding, and Tg(EIIa-cre) 
was segregated out. Genomic DNA extracted from two animals was sequenced to confirm accurate CRE/loxP 
recombination at Hcrtr1. Resulting mice carry the recombined KO/GFP-reporter (Hcrtr1tm1.2Ava MGI: 5637401, 
or Hcrtr1KO-Gfp) allele in all cells (http://www.informatics.jax.org/allele/MGI:5637401). Because the GFP coding 
sequence in this allele does not, unlike the HCRTR1 coding sequence that it replaces, carry a N-terminal signal 
peptide, it generates cytoplasmic GFP, which distributes through soma and neurites. Thus GFP expression reflects 
Hcrtr1 promoter expression, but does not inform about HCRTR1 protein intracellular distribution.
Experimental mice. All mice derived from mating between Hcrtr1flox/flox mice, with one of the two parents 
hemizygous for Tg(Dbh-Cre). These crosses generate two offspring groups: Hcrtr1flox/flox; Tg(Dbh-Cre)+ mice, in 
which NA cells express Cre (Hcrtr1Dbh-CKO, or CKO mice), and Hcrtr1flox/flox littermates, which do not express Cre 
(Hcrtr1Dbh-CTR, or CTR mice). All analyses relied on pair-wise phenotype comparison between these two groups. 
All mice share a C57BL/6NTac X C57BL/6J mixed genetic background. All ECoG data are derived from 10 to 
13-week-old males (weight 27–31 g). Mice were individually housed with food and water ad libitum under an 
LD12:12 cycle (lights-on, i.e., Zeitgeber Time ZT0, at 08:00 AM). All experiments were performed in accordance 
with the Swiss federal law, and using protocols approved by the State of Vaud Veterinary Office.
ECoG/EMG, video and locomotor activity (LMA) recording. Electrodes for differential fronto-parietal 
ECoG and EMG recording were implanted as described134. Mice were allowed to habituate to the EEG-setup 
for a minimal of 10 days, before the recordings were started (Fig. 2). Hardware (EMBLA A-10) and software 
(Somnologica-3) were from Medcare Flaga (EMBLA, Thornton, USA). ECoG and EMG signals were ampli-
fied, filtered, analog-to-digital converted, and stored at 200 Hz. Behavioral states (wake [W], slow-wave-sleep 
[SWS], and paradoxical sleep [PS]) were scored visually in 4-second (4-s) epochs using published criteria135. 
Theta-dominated-waking (TDW) epochs were identified among waking epochs using an ECoG-based algorithm 
as described53. Behavioral monitoring was done using infrared video-cameras84. Locomotor activity was assessed 
using top-mounted passive infrared motion detectors (Visonic Ltd, Tel Aviv, Israel), and analyzed at 1-min reso-
lution using ClockLab software (ActiMetrics, IL, USA).
ECoG power spectral density (PSD) analysis. The ECoG signal was subjected to discrete Fourier trans-
form to yield power density spectra (0.75–90 Hz) in 4 s epochs (0.25 Hz frequency resolution; Hamming window 
function). For each behavioral state and mouse, a mean ECoG spectrum was obtained by averaging spectra of 
all artefact-free epochs of that state and flanked by same-state epochs135. To account for individual differences in 
absolute ECoG power, power density is expressed as % of a baseline ECoG power reference (‘% of BL total power’), 
which is calculated for each mouse across two days, all states, and summation of the 0.75–40 Hz frequency bins. 
This reference is weighted so the relative contribution of each state is identical for all mice135. Reference values 
for CKO and CTR mice did not differ (CKO vs. CTR 1181 ± 127 uV2 vs. 1181 ± 120 uV2, t14 = 0.00105, P = 0.99). 
Power density values across 47.5–52.5 Hz were excluded due to the 50 Hz AC power line noise. Power density 
values across 71.25–77.25 Hz were also excluded due to artefacts of unknown origin present in some mice (EW: 
6/16, 3CKO:3CTR; CC: 4/14, 1CKO:3CTR; Nest experiment: 4/10, 1CKO:3CTR). To rule out that some of the 
power spectral density changes observed in CKO relative to CTR mice are an effect of referencing power density 
values to the individual’s mean ‘total power’ as described above, we also compared the spectral density profiles of 
the two genotypes using their absolute ECoG power values. This yielded significant spectral differences between 
CKO and CTRs in the same frequency bands as the ones obtained with the ‘total power’ reference. Greek symbols 
were used to define specific ECoG frequency ranges as follows: δ (1–4 Hz), inter-δ/θ (4–7 Hz), θ (7.5–11.5 Hz), β 
(15–30 Hz) slow-γ (γ-1: 32–45 Hz), and fast-γ (γ-2: 55–80 Hz). In Fig. 3e inset and Supplementary Table S2, the 
dominant frequency of θ oscillations (θ peak frequency, TPF) was evaluated in each mouse as the frequency at 
which ECoG power density in the average waking spectral profile was highest in the 5–10 Hz range136.
Temporal dynamics of integral PSD in specific frequency bands. The dynamics of ECoG activity 
within specific frequency ranges in waking across various contexts and periods of time were analyzed by dividing 
the period concerned into a same number of time intervals (‘percentiles’) for all animals, each percentile contrib-
uting an equal number of 4 s epochs scored as waking. The number of time intervals, and thus of data-points, was 
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adjusted according to the prevalence of wakefulness (e.g., 6 in baseline light phase, 12 in dark phase, 8 during the 
6-h EW, and 4 in recovery light phase, for Fig. 3d). For each time interval, the mid-points were averaged among 
animals of a given genotype, and mapped back onto real time. Because time-spent-awake (e.g. from cage change 
to SWS-onset) may differ between genotypes, data-points of each genotype do not necessarily coincide in time 
(x-value). ECoG power density in each frequency band was expressed relative to its average value in baseline wake 
(ZT0–24; Figs 5g and 7a), or relative to the ‘baseline total power reference’ described above (Fig. 3d). Genotype 
differences in ECoG power dynamics were statistically evaluated according to the percentile sequence, i.e. CKO 
and CTR mice’ ECoG power values were compared in each successive time percentile.
3D (ECoG Power:Frequency:Time) heatmap analysis of wakefulness. To analyze the time dynam-
ics of the entire ECoG spectrum (0.75–90 Hz) in waking, power density in each 0.25 Hz frequency bin was first 
expressed relative to its average level in baseline light phase waking across the ZT8–12 time interval, then aver-
aged across each time interval, and individual of each genotype. Results are visualized as a 3D ‘heatmap’, with 
larger changes in power density appearing as warmer colors. It is important to note that, in heatmaps, (as in all 
analyses depicting ratios between ECoG power values), the frequencies at which the ECoG power value peaks 
(warm-colored areas) do not represent the precise frequencies of the brain’s actual most powerful oscillations, but 
rather the frequencies at which power densities maximally differ with reference baseline values. These frequencies 
are slightly right-shifted (higher), relative to the frequencies of the actual brain oscillatory rhythms that dynami-
cally respond to the environmental contingencies under analysis. This principle is illustrated in Fig. S4.
Behavioral exposure. Cohorts of CKO and CTR (n = 9:7, CKO:CTR) littermate mice were sequentially 
exposed to four experimental contexts, as their ECoG/EMG data were acquired: (i) baseline (undisturbed) con-
ditions, (ii) EW, (iii) nestbuilding, (iv) transfer to fresh cage. Only uninterrupted high-quality recordings were 
considered for analysis. Hence, (i–ii): n = 9:7; (iii): n = 5:5; (iv): n = 8:6 (CKO:CTR) animals were analyzed.
Spontaneous and enforced wakefulness. Mice were recorded for 3 continuous days, consisting of two undisturbed 
(baseline) days (BL1 + BL2), a 6-h period of ‘gentle handling’134 initiated at light onset (ZT0) of the 3rd day to 
maintain animals awake, and a 18-h ‘recovery’ (undisturbed) period. To avoid sleep during EW, tissue paper was 
introduced in the cage at ZT2 and ZT5, and midway through EW (ZT3), mice were transferred into a fresh cage.
Nest material interaction. Following the day of the EW, mice were left undisturbed for ≥2 days. At dark onset 
(ZT12) of day 6, a square of highly packed shreddable cotton (NestletTM, Ancare, Bellmore, NY, Ref. Nr. 14010) 
was introduced in the cage. Mice were then left undisturbed through the night until light onset and assessment 
of nest morphology. All nests (CKO n = 5; CTR n = 5) were found to score at least 3 according to Gaskill et al.’s59 
nestbuilding scale.
Cage change (CC). Following nest assessment, mice were left undisturbed for another ≥2 days. On ZT3 of 
day 9, mice were transferred from their homecage where the nest had been built to a fresh cage. Latency to 
SWS-onset was defined as the time until the first SWS episode lasting ≥2 min and interrupted by ≤3 epochs 
scored as wakefulness.
Immunofluorescence. ~16-wk old mice were deeply anesthetized with sodium pentobarbital (100 mg/kg, 
i.p.), and transcardially perfused with 4% paraformaldehyde (pH 7.4). Brains were quickly removed, post-fixed 
in the same fixative for 2 h at 4 °C, then immersed successively in 15% (1 h) and 30% sucrose (o/n) at 4 °C, frozen 
and stored at −80 °C until use. Coronal sections (20-µm) were collected on SuperFrost-Plus glass slides, blocked 
in 2% BSA, 5% normal donkey serum, 0.3% TritonX-100 in TBS (pH 7.5) for 30 min at r.t., and antibodies were 
applied in 1% BSA, 0.2% TritonX-100 in TBS, and incubated o/n at 4 °C. When double staining involved the 
HCRTR1 antibody, an additional ‘antigen-retrieval’ step in Sodium Citrate buffer (pH 6.0) buffer at 55o C for 
7 min was applied before blocking and primary antibody incubation. Antibodies were: anti-tyrosine hydroxylase 
(TH) from mouse (Incstar, Cat#22941; 1:5000), anti-green fluorescent protein (GFP) from chicken (Aves Labs, 
Cat#1020; 1:500), anti-CRE from rabbit (Novagen, Cat#69050-3; 1:500), and anti-HCRTR1 from rabbit (Origene 
Cat#TA328918; 1:100–1:500). This HCRTR1 antibody was raised against a 15-aa peptide from the third intracel-
lular loop of rat HCRTR1, i.e. a region downstream of the 126-aa deletion mediated by CRE/loxP recombination 
of the floxed Hcrtr1 allele Secondary antibodies were donkey IgGs coupled to Alexa-594, or -488 fluorophores, 
and were incubated at a 1:500 dilution for 1 h at r.t.
Confocal microscopy. Images were acquired on an inverted Zeiss LSM710 confocal laser-scanning micro-
scope (405, 488, and 561 nm lasers) using a 40x oil objective (EC plan-Neofluar 40x/1.30 Oil DIC M 27). For each 
animal used for cell quantification, sections collected at 4 Bregma levels within the LC (representing approx. 1 out 
of 9 sections) were used (−5.34, −5.40, −5.52, −5.68 mm from Bregma137. Confocal images covering the entire 
LC TH+ cell field were acquired at 8-bit image depth and a frame of 1,024 X 1,024 pixels, and tiled together using 
ZEN software. A square frame centered within the LC field was drawn (1,024 X 1,024 pixels at 40X, as shown in 
Fig. 1b–f), and immunoreactive cell counts were evaluated within that frame using ImageJ software. Images were 
minimally processed in the same manner for the two genotypes.
Statistics. Data were assessed for normal distribution using Shapiro-Wilk normality test, and nonpara-
metric Mann-Whitney statistics were used if the test failed. Otherwise, timecourse and ECoG power spectral 
density analyses were assessed first by two-way ANOVA for factors ‘genotype’ and ‘time-of-day’, or ‘genotype’ 
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and ‘frequency bin’, and their interaction. Only if a significant effect was found for the factor genotype, or/
and the two-factor interaction, were genotypes contrasted by independent t-tests. Within-group effects, such as 
response to EW or nest material, were assessed using paired two-tailed Student’s t-tests. Significance threshold 
was set at p < 0.05. The results are shown as mean ± SEM. Data processing was performed using TMT Pascal 
Multi-Target5 software (Framework Computers, Inc., Brighton, MA, USA), and statistically assessed using 
SPSS V23 (IBM SPSS Statistics, Armonk, NY, USA), or SAS V9.2 (SAS Institute Software Inc., Cary, NC, USA). 
Figures were prepared using SigmaPlot V12.5 (Systat Software Inc., Chicago, IL, USA), and Adobe Illustrator 
CC 2015 (Adobe Systems).
Data Availability
All materials, data and protocols are available upon request with no restriction.
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